Literature DB >> 22235073

New reports examine psychiatric risks of varenicline for smoking cessation.

Bridget M Kuehn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22235073     DOI： 10.1001/jama.2011.1924

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  3 in total

1.  Quitting smoking before and after varenicline: a population study based on two representative samples of US smokers.

Authors:  Shu-Hong Zhu; Sharon E Cummins; Anthony C Gamst; Shiushing Wong; Tyson Ikeda
Journal:  Tob Control       Date:  2015-08-17       Impact factor: 7.552

Review 2.  Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice.

Authors:  Henri-Jean Aubin; Amandine Luquiens; Ivan Berlin
Journal:  Br J Clin Pharmacol       Date:  2014-02       Impact factor: 4.335

3.  Varenicline and risk of psychiatric conditions, suicidal behaviour, criminal offending, and transport accidents and offences: population based cohort study.

Authors:  Yasmina Molero; Paul Lichtenstein; Johan Zetterqvist; Clara Hellner Gumpert; Seena Fazel
Journal:  BMJ       Date:  2015-06-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.